Variable (n=10)                                                              median ± SD
Age (years) 51.00 ± 6.36 (38.00-56.00)
Men, n (%) 8/10 (80%)
Women, n (%) 2/10 (20%)
Weight (kg) 68.07 ± 18.29 (51.07-111.23)
Height (cm) 171.00 ± 7.28 (151.00-185.00)
Time of HIV infection (years) 15.50 ± 4.61 (5.00-17.00)
Use of HAART (years) 13.50 ± 5.17 (2.00-17.00)
CD4+ cells (cells/μL)
Viral load (copies/μL)
Use of PI, n (%)
Use of de RTNI, n (%)
Use of RTNNI, n (%)
479.50 ± 269.43 (160.00-867.00)
69.00 ± 41.55 (<50.00-110.00)
8 (80%)
9 (90%)
7 (70%)
PI – Protease inhibitors
RTNI – Reverse transcriptase nucleoside inhibitors
RTNNI – Reverse transcriptase non-nucleoside inhibitors
Table 1: Characterization of the patients included in the study according to age, body weight, height, time of HIV infection, time of use of highly active antiretroviral therapy (HAART), number of T-CD4+ cells, viral burden and medication class at the time of the study.
Goto home»